R. Thomas Goodrich - Net Worth and Insider Trading

R. Thomas Goodrich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, R. Thomas Goodrich owns 5 companies in total, including ARMO BioSciences Inc (ARMO) , Atara Biotherapeutics Inc (ATRA) , and Adamas Pharmaceuticals Inc (ADMS) among others .

Click here to see the complete history of R. Thomas Goodrich’s form 4 insider trades.

Insider Ownership Summary of R. Thomas Goodrich

Ticker	Comapny	Transaction Date	Type of Owner
ARMO	ARMO BioSciences Inc	2018-01-30	other: Former 10% owner
ATRA	Atara Biotherapeutics Inc	2014-10-15	10 percent owner
ADMS	Adamas Pharmaceuticals Inc	2014-04-15	10 percent owner
		2014-03-07	10 percent owner
		2013-03-21	10 percent owner

R. Thomas Goodrich Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

R. Thomas Goodrich Ownership Network

Ownership Network List of R. Thomas Goodrich

No Data

Ownership Network Relation of R. Thomas Goodrich

R. Thomas Goodrich Owned Company Details

What does ARMO BioSciences Inc do?

Who are the key executives at ARMO BioSciences Inc?

R. Thomas Goodrich is the other: Former 10% owner of ARMO BioSciences Inc. Other key executives at ARMO BioSciences Inc include director & 10 percent owner Orbimed Advisors Llc , 10 percent owner Orbimed Capital Gp V Llc , and 10 percent owner Orbimed Capital Gp Iv Llc .

ARMO BioSciences Inc (ARMO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARMO BioSciences Inc (ARMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARMO BioSciences Inc (ARMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARMO BioSciences Inc (ARMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARMO BioSciences Inc Insider Transactions

No Available Data

What does Atara Biotherapeutics Inc do?

Who are the key executives at Atara Biotherapeutics Inc?

R. Thomas Goodrich is the 10 percent owner of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , EVP & Chief Sci. & Tech Officer Anhco Nguyen , and SVP & CFO Eric J Hyllengren .

Atara Biotherapeutics Inc (ATRA) Insider Trades Summary

Over the past 18 months, R. Thomas Goodrich made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 204,620 shares made by Pascal Touchon , a net sale of 68,971 shares made by Amar Murugan , and a net sale of 64,459 shares made by Eric J Hyllengren .

In summary, during the past 3 months, insiders sold 8,050 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 8,050 shares. During the past 18 months, 27,448 shares of Atara Biotherapeutics Inc (ATRA) were sold and 32,673 shares were bought by its insiders, resulting in a net purchase of 5,225 shares.

Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Atara Biotherapeutics Inc Insider Transactions

No Available Data

What does Adamas Pharmaceuticals Inc do?

Who are the key executives at Adamas Pharmaceuticals Inc?

R. Thomas Goodrich is the 10 percent owner of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .

Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adamas Pharmaceuticals Inc Insider Transactions

No Available Data

What does YuMe Inc do?

Who are the key executives at YuMe Inc?

R. Thomas Goodrich is the 10 percent owner of YuMe Inc. Other key executives at YuMe Inc include President and CEO Paul Porrini , director & 10 percent owner Eric Singer , and director & 10 percent owner Elias Nader .

YuMe Inc (YUME) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of YuMe Inc (YUME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of YuMe Inc (YUME) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

YuMe Inc (YUME)'s detailed insider trading history can be found in Insider Trading Tracker table.

YuMe Inc Insider Transactions

No Available Data

What does Marin Software Inc do?

Who are the key executives at Marin Software Inc?

R. Thomas Goodrich is the 10 percent owner of Marin Software Inc. Other key executives at Marin Software Inc include CFO Robert Bertz , director & Chief Executive Officer Christopher A. Lien , and EVP & Products and Platform Wister Walcott .

Marin Software Inc (MRIN) Insider Trades Summary

Over the past 18 months, R. Thomas Goodrich made no insider transaction in Marin Software Inc (MRIN). Other recent insider transactions involving Marin Software Inc (MRIN) include a net sale of 124,516 shares made by Christopher A. Lien , and a net sale of 66,178 shares made by Robert Bertz .

In summary, during the past 3 months, insiders sold 0 shares of Marin Software Inc (MRIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 31,782 shares of Marin Software Inc (MRIN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 31,782 shares.

Marin Software Inc (MRIN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marin Software Inc Insider Transactions

No Available Data

R. Thomas Goodrich Mailing Address

Above is the net worth, insider trading, and ownership report for R. Thomas Goodrich. You might contact R. Thomas Goodrich via mailing address: 251 Lytton Avenue, Suite 200, Palo Alto Ca 94301.

Discussions on R. Thomas Goodrich

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.